Clinical Trial Update: A Phase Ⅱ Clinical Study of 9MW1411 Injection in Acute Bacterial Skin and Skin Structure Infections [Phase 2]

View source ↗

Summary

Phase 2 clinical study update for 9MW1411 injection in acute bacterial skin and skin structure infections is ongoing with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Infection

Drugs mentioned

• 9MW1411

Snippet

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. | Conditions: Skin Infection | Phase 2 | Status: UNKNOWN